Vitamin D
Cholecalciferol (Vitamin D₃)
For preventing and treating deficiency and supporting bone health in at-risk groups, vitamin D is effective with high confidence. For broad disease prevention in already-replete adults, the largest trials are null, and confidence in that null is also high. A few extra-skeletal uses remain promising but unproven.
How confident is BioSignal?
Our overall position, and how sure we are of it across each dimension — including where we are not sure at all.
High confidence
For preventing and treating deficiency and supporting bone health in at-risk groups, vitamin D is effective with high confidence. For broad disease prevention in already-replete adults, the largest trials are null, and confidence in that null is also high. A few extra-skeletal uses remain promising but unproven.
Well-supported by consistent, high-quality evidence.
Biological Role
Vitamin D's role as a hormone precursor governing calcium/phosphate handling and bone mineralization is well established physiology.
Human Evidence
Large, well-conducted randomized trials and an authoritative guideline provide strong human evidence, both for benefit in deficiency and for the absence of benefit in replete adults.
Supplement Benefit
Benefit is clear for correcting deficiency and supporting bone, but supplementing already-replete people does not reduce fractures, cancer, cardiovascular events, or mortality.
Broader Claims
Extra-skeletal claims — autoimmune disease, diabetes in high-risk prediabetes, respiratory infection — are emerging, mixed, or subgroup-dependent, not established.
Safety Confidence
At recommended intakes vitamin D is well tolerated; risk arises from chronic excess (hypercalcemia) and from high intermittent bolus dosing.
Research Activity
Vitamin D remains an active research area spanning deficiency-targeted trials, autoimmune signals, diabetes subgroups, and dosing safety.
Where the evidence stands today
How mature the science is, what kinds of evidence exist, and — the part nobody else prints — what is still missing.
8/9
steps proven in humans
Evidence-rich
Proven at every applicable step — rare, and worth noticing.
Guideline / regulatory support
ProvenAuthoritative guidance exists on intake and on deficiency, and it does NOT recommend routine testing or supplementation of healthy replete adults.
Clinical outcomes
LimitedSupported for deficiency, rickets and osteomalacia, and for bone health in at-risk groups. NULL in large trials for cancer, cardiovascular disease, fractures in the general population, and all-cause mortality. This rung is where the vitamin D story turned.
Large human RCTs
ProvenVery large trials were conducted specifically to test the extra-skeletal claims.
Small human outcome trials
ProvenNumerous — and this is where most of the positive signals came from.
Human safety data
ProvenExtensive. Toxicity is real but requires sustained very high intake.
Human biomarker / pharmacology
ProvenSupplementation reliably raises serum 25-hydroxyvitamin D — the biomarker moves exactly as predicted. That it moves, and the outcomes do not, is the central lesson of this record.
Animal
ProvenSubstantial, including immune and metabolic effects that did not translate.
Cell / in vitro
ProvenVitamin D receptor signalling is extensively characterised.
Mechanistic plausibility
ProvenA hormone precursor with receptors in most tissues — which is precisely why the extra-skeletal hypotheses were so plausible.
The bottom line
What we know, what we think, what we don't know — and what would change our mind.
What We Know
Vitamin D is required for calcium handling and bone mineralization, and correcting deficiency prevents and treats rickets in children and osteomalacia in adults.
What We Think
Benefit concentrates where a deficiency exists to correct. In already-replete adults, routine supplementation does not prevent fractures, cancer, cardiovascular disease, or death.
What We Don't Know
The right blood level to target for non-bone outcomes, whether benefits hide in the deficient subgroups of the big trials, and whether the autoimmune and cancer-mortality signals are real.
Active Research
Research is testing vitamin D in deficient populations, replicating an autoimmune-disease signal, probing high-risk prediabetes, and clarifying daily-versus-bolus dosing safety.
What Could Change Our Mind
Large trials enrolling genuinely deficient populations, or confirmation of the autoimmune and cancer-mortality signals, could expand confidence in benefits beyond deficiency correction.
The biggest myth
“Everyone should take vitamin D and get their level tested”
The current guideline recommends against routine testing in generally healthy people and does not endorse universal higher-dose supplementation, instead targeting specific groups. Universal testing and supplementation are not supported.
Ask BioSignal
Still have a question about vitamin d?
Answers are retrieved from this record and the rest of the knowledge graph — never generated.
Why people take vitamin d
Popularity is not evidence — but it is not stupid either. This explains the interest on its own terms.
Vitamin D became the most-tested and most-taken supplement in the world on the strength of a genuinely exciting hypothesis: receptors sit in almost every tissue, low levels track with almost every disease, so raising it should improve almost everything. It was one of the best-funded hypotheses in modern nutrition, and it was tested properly, at enormous scale — and it failed. People remain interested because the observational story is still everywhere, and because a blood test that comes back 'low' feels like a problem with a solution. This record exists to explain, without condescension, why the trials went the way they did.
If you're here because…
Jump straight to the part of the evidence that answers your question.
Approval, safety and regulatory
What it is approved for, who should be careful, what remains unknown — and the limits of what this evidence can tell you.
Regulatory status
Dietary supplement. Prescription forms exist for deficiency
Availability
Over-the-counter supplement
Sport (WADA)
Not prohibited
Known safety profile
At recommended intakes vitamin D is well tolerated. The main risks arise from excess and from dosing regimen, not from adequacy.
Common issues
- Generally well tolerated at recommended intakes
- Symptoms of excess (e.g. nausea) reflect hypercalcemia from sustained very high doses
Use caution if
- People with hypercalcemia (clinician oversight required)
- People with granulomatous diseases such as sarcoidosis, or some lymphomas
- People with primary hyperparathyroidism or chronic kidney disease
- Anyone considering high doses or megadosing (avoid without clinician guidance)
Long-term unknowns
The best status threshold for non-skeletal outcomes, and whether benefits exist specifically in deficient subgroups, remain unresolved; effects in some under-studied groups are less fully characterised.
Limits of this evidence
Most large trials enrolled already-replete populations, limiting power to detect deficiency-specific benefit; bolus versus daily dosing complicates comparison; long-latency outcomes such as cancer may exceed trial length. High intermittent bolus dosing has been associated with increased falls in some trials.
Demand, separated from evidence
Every claim people make about this, counted against what the evidence actually showed.
BioSignal evaluated 11 popular claims about vitamin d.
Here is where each one landed — including the claims of harm, where “not established” is reassuring rather than damning.
- Supported by evidence
- 1
- Mixed evidence
- 3
- Insufficient evidence
- 1
- Not established
- 6
Popularity is not evidence. This is simply a count of every claim BioSignal evaluated on this page, sorted by what the evidence actually showed — the full reasoning behind each verdict is in the Evidence Review below.
Supported by evidence
- Vitamin D is required for bone health and corrects rickets and osteomalacia
Mixed evidence
- Vitamin D prevents type 2 diabetes
- Vitamin D prevents respiratory infections and boosts immunity
- Vitamin D prevents falls in older adults
Insufficient evidence
- Vitamin D reduces the risk of autoimmune disease
Not established
- Everyone should take vitamin D and get their level tested
- Vitamin D supplementation prevents fractures in the general population
- Vitamin D prevents cancer
- Vitamin D prevents cognitive decline or dementia
- Vitamin D prevents cardiovascular disease
- Vitamin D reduces all-cause mortality
The evidence review
Every claim with the reasoning behind its verdict, the doses actually studied, where scientists agree and disagree, and the questions still open.
What people claim
Every popular claim, with BioSignal’s verdict and how confident we are in it. The verdicts are always visible; open any claim to read the evidence behind it.
Vitamin D is required for bone health and corrects rickets and osteomalaciaSupportedHigh confidence
Established physiology and global consensus: adequate vitamin D is necessary for normal mineralization, and correcting deficiency prevents and treats nutritional rickets and osteomalacia. This is vitamin D's core, non-negotiable role.
Vitamin D supplementation prevents fractures in the general populationNot establishedModerate confidence
In a large trial of midlife and older adults not selected for deficiency, vitamin D did not reduce fractures versus placebo. The result speaks to replete adults, not to deficient or osteoporotic individuals.
Vitamin D prevents cancerNot establishedModerate confidence
In the VITAL trial, vitamin D did not reduce cancer incidence. An exploratory hypothesis about reduced cancer mortality or advanced disease remains unproven and is not a reason to supplement.
Vitamin D prevents cognitive decline or dementiaNot establishedModerate confidence
Low vitamin D levels are consistently associated with dementia risk in observational studies, but supplementation trials have not shown cognitive benefit. This is a strong example of an association that has not survived randomisation — low vitamin D may be a marker of poor health and low sun exposure rather than a cause of cognitive decline.
Vitamin D prevents cardiovascular diseaseNot establishedModerate confidence
The VITAL trial found no reduction in major cardiovascular events with vitamin D versus placebo in a largely replete population. Vitamin D is not a cardiovascular-prevention therapy.
Vitamin D reduces all-cause mortalityNot establishedModerate confidence
The D-Health trial in older adults found no reduction in all-cause mortality, and guidance concurs that routine supplementation does not lower mortality in general populations. Vitamin D is not a longevity intervention for replete adults.
Vitamin D prevents type 2 diabetesMixedLimited evidence
The D2d trial in prediabetes was null overall, but subgroup and deficiency-focused analyses suggested possible benefit, on which the guideline suggests vitamin D specifically for high-risk prediabetes. Not a general diabetes-prevention tool.
Vitamin D reduces the risk of autoimmune diseaseInsufficient evidenceLimited evidence
A VITAL analysis associated vitamin D with a modest reduction in incident autoimmune disease — one of the more credible extra-skeletal signals, but a single major trial that warrants replication. Promising, not established.
Vitamin D prevents respiratory infections and boosts immunityMixedLimited evidence
A large meta-analysis found at most a small protective effect against acute respiratory infections, with substantial heterogeneity and results sensitive to dose and baseline status. Not a reliable way to boost immunity in replete people.
Vitamin D prevents falls in older adultsMixedModerate confidence
Guideline synthesis does not support routine higher-dose vitamin D for fall prevention, and flags that high intermittent bolus dosing has been associated with more falls. Ensure adequacy with modest daily dosing rather than megadose boluses.
Doses used in human studies
What was actually given to participants in the research. These are descriptions of studies, not recommendations.
Most healthy adults
- Intervention
- Oral vitamin D (reference intake)
- Dose
- ~600 IU/day
- Duration
- Ongoing
- Outcome
- Meeting recommended dietary intake
- Notes
- Reference intake for most ages; educational, not a prescription
Older adults
- Intervention
- Oral vitamin D (reference intake)
- Dose
- ~800 IU/day
- Duration
- Ongoing
- Outcome
- Adequacy and bone health
- Notes
- Higher reference intake for older ages
Midlife and older adults (VITAL)
- Intervention
- Oral vitamin D₃, daily
- Dose
- 2000 IU/day
- Duration
- Multiple years
- Outcome
- Cancer, cardiovascular events, fractures
- Notes
- Largely replete population; hard endpoints were null
Adults with prediabetes (D2d)
- Intervention
- Oral vitamin D₃, daily
- Dose
- 4000 IU/day
- Duration
- Multiple years
- Outcome
- Progression to type 2 diabetes
- Notes
- Overall null; subgroup signals hypothesis-generating
Older adults (D-Health)
- Intervention
- Oral vitamin D₃, monthly bolus
- Dose
- 60,000 IU/month
- Duration
- Multiple years
- Outcome
- All-cause mortality
- Notes
- Bolus regimen; no mortality reduction observed
Where scientists agree — and don’t
Agreed
- Adequate vitamin D is required for calcium/phosphate handling and normal bone mineralization.
- Correcting deficiency prevents and treats rickets and osteomalacia.
- In already-replete adults, routine supplementation does not reduce fractures, cancer, cardiovascular events, or all-cause mortality.
- At recommended intakes vitamin D is well tolerated; excess and high-bolus dosing carry the main risks.
Debated
- The optimal blood level to target for non-skeletal outcomes.
- The value of population-wide screening and supplementation.
- How strongly to weight subgroup and post-hoc signals (cancer mortality, diabetes subgroups).
Unknown
- Whether the large null trials conceal real benefits in their deficient subgroups.
- Whether the autoimmune-disease and cancer-mortality signals are real.
- The best dose, form, and frequency, and effects in under-studied groups.
What remains unknown
- What is the right blood level to target for outcomes beyond bone?
- Do the big null trials hide real benefits in their deficient subgroups?
- Is the modest autoimmune-disease signal real and replicable?
- Does daily (rather than bolus) dosing in deficient populations change outcomes?
Questions people actually ask
What is vitamin D?
Vitamin D is not strictly a vitamin — it is the precursor to a hormone. It is made in skin on sunlight exposure or obtained from diet and supplements, then converted in the body to an active form that regulates calcium and phosphate. The form measured in blood to define status is 25-hydroxyvitamin D.
How does vitamin D work?
The active hormone acts through a receptor expressed in many tissues. Its best-defined role is promoting intestinal calcium and phosphate absorption to support bone mineralization. Because the receptor is widely expressed, immune and metabolic roles are biologically plausible — but plausibility is not proof, and randomized trials settle whether supplementing replete people helps.
How is vitamin D studied?
Evidence spans established deficiency physiology, a global rickets consensus, and an authoritative endocrine-society guideline, alongside very large randomized trials (such as VITAL, D-Health, and D2d) testing hard outcomes like fractures, cancer, cardiovascular events, mortality, and diabetes. A recurring theme is that most large trials enrolled already-replete people.
Should everyone take vitamin D or get tested?
The current guideline recommends against routine testing in generally healthy people and does not endorse universal higher-dose supplementation. It suggests empiric vitamin D for specific groups instead. Targeting the people who actually benefit is more defensible than treating the whole population.
Can you take too much vitamin D?
Yes. At recommended intakes vitamin D is well tolerated, but sustained very high doses can cause hypercalcemia, with harms that can include kidney stones and, in severe cases, renal and cardiovascular effects. High intermittent bolus dosing has also been linked to more falls. More is not better. This is educational information, not medical advice.
Practical takeaways
- Vitamin D is essential for correcting deficiency and supporting bone; ensure adequacy in at-risk groups.
- It is not a general-population preventive for fractures, cancer, cardiovascular disease, or mortality in replete adults.
- Benefit concentrates where a deficiency exists to correct — the single most useful lens for reading the evidence.
- A few extra-skeletal uses (autoimmune, high-risk prediabetes, infection) are promising but unproven.
- More is not better: chronic very high doses risk hypercalcemia, and high bolus dosing may increase falls.
How it works
The mechanism comes last on purpose. A compelling explanation of how something might work is the easiest part of the story to tell, and the part most likely to outlive the evidence for it.
Vitamin D's role as a hormone precursor governing calcium/phosphate handling and bone mineralization is well established physiology.
How we found out
Deficiency Physiology
Vitamin D was established as essential for calcium handling and bone mineralization, with deficiency causing rickets and osteomalacia.
Global Deficiency Consensus
Consensus recommendations formalised prevention and management of nutritional rickets, cementing the deficiency-correction role.
Large Prevention Trials
Very large randomized trials tested broad disease prevention in replete adults and consistently found null results for fractures, cancer, cardiovascular events, and mortality.
Current Guidance & Open Questions
A current guideline targets specific groups and advises against routine testing, while research continues on autoimmune, diabetes, and infection signals and on dosing safety.
References
Verified sources. BioSignal does not print a citation it has not checked.
- 01
Vitamin D supplements and prevention of cancer and cardiovascular disease (VITAL)
N Engl J Med 380(1):33-44 · 2019
- 02
Supplemental vitamin D and incident fractures in midlife and older adults (VITAL)
N Engl J Med 387(4):299-309 · 2022
- 03
Vitamin D and marine omega-3 fatty acid supplementation and incident autoimmune disease (VITAL)
BMJ 376:e066452 · 2022
- 04
The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality
Lancet Diabetes Endocrinol 10(2):120-128 · 2022
- 05
Vitamin D supplementation and prevention of type 2 diabetes (D2d)
N Engl J Med 381(6):520-530 · 2019
- 06
Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials
Lancet Diabetes Endocrinol 9(5):276-292 · 2021
- 07
Global consensus recommendations on prevention and management of nutritional rickets
J Clin Endocrinol Metab 101(2):394-415 · 2016
- 08
Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline
J Clin Endocrinol Metab 109(8):1907-1947 · 2024
Version history
Version 1.0
First published Signal Record for the Alpha launch, distilled from Gold Standard Record #002. Verified references attached. Future versions will track scientific updates, evidence changes, and review history.
Continue exploring
Three places this record leads next.